116 related articles for article (PubMed ID: 38626431)
1. Long-term prognosis of patients with gallbladder carcinoma after curative-intent resection based on changes in the ratio of carbohydrate antigen 19-9 to total bilirubin (CA19-9/TB): a multicenter retrospective cohort study.
Li XL; Liu ZP; Su XX; Gong Y; Yang YS; Zhao XL; Li ZM; Ding JJ; Zhu Y; Yin DL; Yu C; Zhou JX; Zhang D; Ding R; Chen W; Cheng Y; Yue P; Wang ZR; Zhang YQ; Jiang Y; Yin XY; Bai J; Dai HS; Lau WY; Chen ZY;
Int J Surg; 2024 Apr; 110(6):3580-90. PubMed ID: 38626431
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of carbohydrate antigen 19-9 in patients undergoing resection of biliary tract cancer.
Yamashita S; Passot G; Aloia TA; Chun YS; Javle M; Lee JE; Vauthey JN; Conrad C
Br J Surg; 2017 Feb; 104(3):267-277. PubMed ID: 28052308
[TBL] [Abstract][Full Text] [Related]
3. Importance of Normalization of Carbohydrate Antigen 19-9 in Patients With Intrahepatic Cholangiocarcinoma.
Li H; Feng Y; Liu C; Li J; Li J; Wu H; Wang G; Li D
Front Oncol; 2021; 11():780455. PubMed ID: 35004301
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of preoperative and postoperative CA 19-9 normalization in pancreatic adenocarcinoma treated with neoadjuvant therapy or surgery first.
DiPeri TP; Newhook TE; Prakash LR; Ikoma N; Maxwell JE; Kim MP; Lee JE; Katz MHG; Tzeng CD
J Surg Oncol; 2022 Nov; 126(6):1021-1027. PubMed ID: 35726394
[TBL] [Abstract][Full Text] [Related]
5. A novel prognostic system combining carbonic anhydrase II and preoperative CA19-9 for intrahepatic cholangiocarcinoma after curative resection.
Zhang J; Huang Q; Yang Y; Zhang J; Fang X; Yang Y; Liang H; Wang W; Wang Y
Cancer; 2023 Apr; 129(7):1030-1040. PubMed ID: 36625486
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Impact of Perioperative CA19-9 Levels in Patients with Resected Perihilar Cholangiocarcinoma.
Lee JW; Lee JH; Park Y; Kwon J; Lee W; Song KB; Hwang DW; Kim SC
J Clin Med; 2021 Mar; 10(7):. PubMed ID: 33805079
[TBL] [Abstract][Full Text] [Related]
7. Prognosis Associated With CA19-9 Response Dynamics and Normalization During Neoadjuvant Therapy in Resected Pancreatic Adenocarcinoma.
Newhook TE; Vreeland TJ; Griffin JF; Tidwell RSS; Prakash LR; Koay EJ; Ludmir EB; Smaglo BG; Pant S; Overman M; Wolff RA; Ikoma N; Maxwell J; Kim MP; Lee JE; Katz MHG; Tzeng CD
Ann Surg; 2023 Mar; 277(3):484-490. PubMed ID: 36649067
[TBL] [Abstract][Full Text] [Related]
8. Preoperative serum CA19-9 should be routinely measured in the colorectal patients with preoperative normal serum CEA: a multicenter retrospective cohort study.
Li Z; Zhu H; Pang X; Mao Y; Yi X; Li C; Lei M; Cheng X; Liang L; Wu J; Ding Y; Yang J; Sun Y; Zhang T; You D; Liu Z
BMC Cancer; 2022 Sep; 22(1):962. PubMed ID: 36076189
[TBL] [Abstract][Full Text] [Related]
9. Ratio of CA19-9 level to total bilirubin as a novel prognostic indicator in patients with pancreatic head carcinoma following curative resection.
Xu WL; Wang J; Lyu SC; Zhou L; He Q; Lang R
Gland Surg; 2021 Mar; 10(3):980-991. PubMed ID: 33842242
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of changes in the level of carbohydrate antigen 19-9 in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Zheng Z; Wang X; Huang Y; Lu X; Chi P
Colorectal Dis; 2020 Dec; 22(12):2068-2077. PubMed ID: 32936987
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of neutrophil-lymphocyte ratio and carbohydrate antigen 19-9 in patients with gallbladder carcinoma.
Liu F; Hu HJ; Ma WJ; Yang Q; Wang JK; Li FY
Medicine (Baltimore); 2019 Feb; 98(8):e14550. PubMed ID: 30813165
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of combined preoperative PLR and CA19-9 in patients with resectable gallbladder cancer.
Liu F; Wang JK; Ma WJ; Hu HJ; Lv TR; Jin YW; Li FY
Updates Surg; 2024 Mar; ():. PubMed ID: 38436922
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Serum CA19-9 and Perioperative CA-125 Levels in Ovarian Clear Cell Carcinoma.
Zhu J; Jiang L; Wen H; Bi R; Wu X; Ju X
Int J Gynecol Cancer; 2018 Jul; 28(6):1108-1116. PubMed ID: 29781825
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Carbohydrate Antigen 19-9 and the Surgical Margin in Extrahepatic Cholangiocarcinoma.
Yamamoto R; Sugiura T; Ashida R; Ohgi K; Yamada M; Otsuka S; Uesaka K
Ann Gastroenterol Surg; 2022 Mar; 6(2):307-315. PubMed ID: 35261957
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant immunotherapy improves recurrence-free and overall survival following surgical resection for intermediate/advanced hepatocellular carcinoma
Xu X; Wang MD; Xu JH; Fan ZQ; Diao YK; Chen Z; Jia HD; Liu FB; Zeng YY; Wang XM; Wu H; Qiu W; Li C; Pawlik TM; Lau WY; Shen F; Lv GY; Yang T
Front Immunol; 2023; 14():1322233. PubMed ID: 38268916
[TBL] [Abstract][Full Text] [Related]
16. Preoperative CA19-9 and GGT ratio as a prognostic indicator in ampullary carcinoma.
Chen RQ; Zhang ZL; Jia YM; Chen RX; Peng L
BMC Gastroenterol; 2023 Mar; 23(1):72. PubMed ID: 36915042
[TBL] [Abstract][Full Text] [Related]
17. Textbook outcome in gallbladder carcinoma after curative-intent resection: a 10-year retrospective single-center study.
Li Q; Liu H; Gao Q; Xue F; Fu J; Li M; Yuan J; Chen C; Zhang D; Geng Z
Chin Med J (Engl); 2023 Jul; 136(14):1680-1689. PubMed ID: 37166217
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy analysis of surgical combined with postoperative adjuvant therapy for T3 gallbladder carcinoma: a multicenter retrospective study].
Yang FC; Hu J; Su TH; Geng ZM; Zhang K; Ding J; Lei ZQ; Yi B; Li JD; Tang ZH; Cheng ZJ; Qiu YH
Zhonghua Wai Ke Za Zhi; 2023 Oct; 61(10):863-870. PubMed ID: 37653988
[No Abstract] [Full Text] [Related]
19. Tumor Burden Score Stratifies Prognosis of Patients With Intrahepatic Cholangiocarcinoma After Hepatic Resection: A Retrospective, Multi-Institutional Study.
Li H; Liu R; Qiu H; Huang Y; Liu W; Li J; Wu H; Wang G; Li D
Front Oncol; 2022; 12():829407. PubMed ID: 35330712
[TBL] [Abstract][Full Text] [Related]
20. High pretreatment serum CA19-9 level predicts a poor prognosis for patients with stage III colon cancer after curative resection and adjuvant chemotherapy.
Zhou W; Yang F; Peng J; Wang F; Lin Y; Jiang W; Yang X; Li L; Lu Z; Wan D; Pan Z; Fan W
J Cancer; 2019; 10(16):3810-3818. PubMed ID: 31333798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
